about
Spotlight on ixazomib: potential in the treatment of multiple myelomaSiltuximab (CNTO 328): a promising option for human malignanciesA CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.Molecularly targeted therapies in multiple myeloma3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma.Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.
P2860
Q26774440-E2012FC8-B383-4F01-81B5-316A7D2FC419Q28082572-868080D2-5EB7-4C5A-B149-F565A62E9633Q37032148-FBFEC768-DF7A-4318-86B8-A5CFA10499C4Q38211866-B2A50D2F-27CA-45C9-8326-0A0D00E307CAQ38832888-A74FCFD7-77BB-4574-8178-06D57F75E480Q39139112-1F0C4B76-F212-468A-B8B4-245765387161Q42598619-E41E4021-33BC-4783-88A6-2A1D6D470BF8Q48073647-7CA124D2-C295-4BD6-B9EF-6E7052308A2FQ49358494-A3F633BA-7B06-4B8C-A08C-F24F536F44C2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Contemporary drug therapies for multiple myeloma.
@en
type
label
Contemporary drug therapies for multiple myeloma.
@en
prefLabel
Contemporary drug therapies for multiple myeloma.
@en
P1433
P1476
Contemporary drug therapies for multiple myeloma.
@en
P2093
P de la Puente
P304
P356
10.1358/DOT.2013.49.9.2020941
P577
2013-09-01T00:00:00Z